Please assess the completion status of the following clinical trial:

Trial Title: Troponin I Release After High Diuretic Doses

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* signs/symptoms of heart failure;~* New York Heart Association (NYHA) functional Class III or IV on admission due to an exacerbation of symptoms with at least 1 class deterioration;~* evidence of systolic dysfunction on echocardiographic examination on admission (EF\<45%);~* BNP levels on admission \> 100pg/mL~Exclusion Criteria:~* NYHA class \< III on admission or without a NYHA class improvement on discharge;~* acute coronary syndrome,~* pulmonary thromboembolism,~* cardiac tamponade,~* pericarditis,~* renal insufficiency (serum creatinine \<2,5 mg/dL, BUN \<60 mg/dL) or those on dialysis;~* chronic liver disease,~* pleuro-pneumonia,~* blood and autoimmune diseases,~* concomitant other important co-morbidity,~* cerebral vascular disease,~* dementia,~* cancer,~* uncompensated diabetes,~* took non-steroid anti-inflammatory drugs (NSAID)~* declining to provide informed consent,~* patients requiring pacemaker implantation and those with issues of excessive alcohol consumption

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Study Arms:
- High doses furosemide (Type: PLACEBO_COMPARATOR): administration of furosemide alone
- HSS plus furosemide (Type: EXPERIMENTAL): administration of hypertonic saline solution plus high doses of furosemide bid

Based on this trial design, predict the completion outcome and termination type (if applicable).